Bone performance of ultraviolet light activated dental implants used for overdentures in patient with moderately controlled diabetes
- Conditions
- Health Condition 1: K081- Complete loss of teeth
- Registration Number
- CTRI/2024/07/069739
- Lead Sponsor
- Dr Harshal Jain
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
a Subjects 18 years and above
b Completely edentulous upper and lower arches
c Edentulous ridge classification as per American College of Prosthodontists (ACP) type III & type lV
d Able to provide consent
e Patients with moderately controlled type 2 diabetes mellitus
f HbA1C value 6.9-8.0
g Patients whose consent for surgical placement of implants is obtained from physician treating them for diabetes
a Patients with systemic diseases or metabolic disorders other than diabetes if any which may impact study
b Patients is currently a smoker or quit smoking less than 1 year
c Pregnant and lactating women
d Patients in whom bone grafting is indicated along with the placement of implants
e Patients in whom immediate implants are placed
f Patients who have received or are on chemotherapy or radiotherapy or drugs that interfere with implant integration
g Patients having any surgical or congenital mandibular defects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method implant stability quotient and <br/ ><br>marginal bone loss <br/ ><br>Timepoint: implant stability quotient and marginal bone loss at baseline 2 months 3 months 6 months and 12 months
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.